Lv53
930 积分 2025-01-26 加入
Development of a Commercial Manufacturing Process for Vepdegestrant, an Orally Bioavailable PROTAC Estrogen Receptor Degrader for the Treatment of Breast Cancer
15天前
已完结
Discovery of selective NaV1.8 inhibitors based on 5-chloro-2-(4,4-difluoroazepan-1-yl)-6-methyl nicotinamide scaffold for the treatment of pain
20天前
已完结
Recent Advances in Biocatalytic Preparation of Chiral Sulfoxides
21天前
已完结
A closer look at ligand specificity for cellular activation of NOD2 with synthetic muramyl dipeptide analogues
27天前
已完结
Stereoselective Nucleophilic Di‐ and Monofluoro(sulfoximidoyl)Methylation of C═C Bonds: Remote Neighboring Group Participation Enables Facile Access to Chiral γ‐Fluorinated Amines
1个月前
已完结
Alkyl Fluoride Synthesis via Cu-Mediated Deacetylative Fluorination
1个月前
已完结
A Convenient Cascade Strategy Towards the Synthesis of Novel Substituted Morpholinopyrimidines and Pyrimidooxazapines
1个月前
已完结
Bathocuproine-Enabled Nickel-Catalyzed Selective Ullmann Cross-Coupling of Two sp2-Hybridized Organohalides
1个月前
已完结
Selective Ni-Catalyzed Cross-Electrophile Coupling of Heteroaryl Chlorides and Aryl Bromides at 1:1 Substrate Ratio
2个月前
已完结
Efficient Manufacturing Process for the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) via a Crystallization-Driven Diastereoselective Pictet–Spengler Condensation
2个月前
已完结
皖公网安备34019202002308
